A share price of 60 Degrees Pharmaceuticals Inc [SXTP] is currently trading at $1.06, up 37.52%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SXTP shares have gain 29.25% over the last week, with a monthly amount drifted -20.90%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
60 Degrees Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $0.70 and $7.20. 60 Degrees Pharmaceuticals Inc [NASDAQ: SXTP] shares were valued at $1.06 at the most recent close of the market.
Analyzing the SXTP fundamentals
Trailing Twelve Months sales for 60 Degrees Pharmaceuticals Inc [NASDAQ:SXTP] were 0.46M which represents 16.85% growth. Gross Profit Margin for this corporation currently stands at 0.08% with Operating Profit Margin at -21.19%, Pretax Profit Margin comes in at -17.68%, and Net Profit Margin reading is -17.48%. To continue investigating profitability, this company’s Return on Assets is posted at -1.06, Equity is -1.49 and Total Capital is -1.56. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9207 points at the first support level, and at 0.7815 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1996, and for the 2nd resistance point, it is at 1.3393.
Ratios To Look Out For
To put it in perspective, the Current Ratio for 60 Degrees Pharmaceuticals Inc [NASDAQ:SXTP] is 5.26. Further, the Quick Ratio stands at 4.91, while the Cash Ratio is 2.52. Considering the valuation of this stock, the price to sales ratio is 5.29.
Transactions by insiders
Recent insider trading involved XU CHERYL, Director, that happened on Dec 13 ’24 when 6000.0 shares were purchased. Director, XU CHERYL completed a deal on Dec 12 ’24 to buy 5000.0 shares. Meanwhile, Director XU CHERYL bought 2000.0 shares on Dec 16 ’24.
